
Melody Noel Brown
Examiner (ID: 10713, Phone: (571)272-2599 , Office: P/2917 )
Most Active Art Unit | 2917 |
Art Unit(s) | 2911, 2901, 2915, 2917 |
Total Applications | 11779 |
Issued Applications | 11665 |
Pending Applications | 10 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10154620
[patent_doc_number] => 09186373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/977453
[patent_app_country] => US
[patent_app_date] => 2011-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7853
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977453
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/977453 | SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer | Dec 26, 2011 | Issued |
Array
(
[id] => 9281444
[patent_doc_number] => 20140031412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'METHOD OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/996984
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16639
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996984 | Method of treatment | Dec 19, 2011 | Issued |
Array
(
[id] => 10123565
[patent_doc_number] => 09157919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Method for identifying biologically active oligonucleotides capable of modulating the immune system'
[patent_app_type] => utility
[patent_app_number] => 13/995304
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 31
[patent_no_of_words] => 12739
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995304 | Method for identifying biologically active oligonucleotides capable of modulating the immune system | Dec 19, 2011 | Issued |
Array
(
[id] => 9122177
[patent_doc_number] => 20130289099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'ABCG1 GENE AS A MARKER AND A TARGET GENE FOR TREATING OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/993726
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14042
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993726
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993726 | ABCG1 GENE AS A MARKER AND A TARGET GENE FOR TREATING OBESITY | Dec 15, 2011 | Abandoned |
Array
(
[id] => 9597786
[patent_doc_number] => 20140194467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'PLASMA CELL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/993834
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11083
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993834 | PLASMA CELL DISORDERS | Dec 12, 2011 | Abandoned |
Array
(
[id] => 10162759
[patent_doc_number] => 09193973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Compositions and methods for increasing erythropoietin (EPO) production'
[patent_app_type] => utility
[patent_app_number] => 13/992334
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 53365
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992334 | Compositions and methods for increasing erythropoietin (EPO) production | Dec 8, 2011 | Issued |
Array
(
[id] => 9223635
[patent_doc_number] => 20140018410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KLF-1 AND BCL11A GENES'
[patent_app_type] => utility
[patent_app_number] => 13/992669
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 52685
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992669
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992669 | Compositions and methods for inhibiting expression of klf-1 and bcl11a genes | Dec 8, 2011 | Issued |
Array
(
[id] => 9004536
[patent_doc_number] => 20130225661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'Inhibitors Of SP140 And Their Use In Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/883091
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12585
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883091
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883091 | Inhibitors of SP140 and their use in therapy | Nov 22, 2011 | Issued |
Array
(
[id] => 9122176
[patent_doc_number] => 20130289098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/977797
[patent_app_country] => US
[patent_app_date] => 2011-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13801
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977797
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/977797 | Compositions and methods for treatment of ovarian cancer | Nov 19, 2011 | Issued |
Array
(
[id] => 9295400
[patent_doc_number] => 20140039035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/988095
[patent_app_country] => US
[patent_app_date] => 2011-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15899
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988095
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988095 | COMPOSITIONS AND METHODS FOR TREATING OBESITY | Nov 17, 2011 | Abandoned |
Array
(
[id] => 9206075
[patent_doc_number] => 20140005252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'MODULATION OF ALPHA SYNUCLEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/988296
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26971
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988296 | Modulation of alpha synuclein expression | Nov 16, 2011 | Issued |
Array
(
[id] => 9042461
[patent_doc_number] => 20130245099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ANTAGONAT COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/988063
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16484
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988063
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988063 | Antagonat compositions and methods of use | Nov 16, 2011 | Issued |
Array
(
[id] => 10608324
[patent_doc_number] => 09328346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-03
[patent_title] => 'Polycomb-associated non-coding RNAs'
[patent_app_type] => utility
[patent_app_number] => 13/884670
[patent_app_country] => US
[patent_app_date] => 2011-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 68
[patent_no_of_words] => 62375
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884670 | Polycomb-associated non-coding RNAs | Nov 11, 2011 | Issued |
Array
(
[id] => 10863951
[patent_doc_number] => 08889649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Composition containing antisense oligonucleotide to micro RNA'
[patent_app_type] => utility
[patent_app_number] => 13/884436
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8668
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884436
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884436 | Composition containing antisense oligonucleotide to micro RNA | Nov 9, 2011 | Issued |
Array
(
[id] => 9206073
[patent_doc_number] => 20140005250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Compositions and Methods for Increasing Drug Efficacy in Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/883862
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 15796
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883862
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883862 | Compositions and methods for increasing drug efficacy in cancer | Nov 6, 2011 | Issued |
Array
(
[id] => 8707497
[patent_doc_number] => 20130064786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/288167
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5048
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288167 | SiRNA hydrogel and method for manufacturing the same | Nov 2, 2011 | Issued |
Array
(
[id] => 9331188
[patent_doc_number] => 20140057970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'Use of Hepcidin Binding Nucleic Acids for Depletion of Hepcidin From the Body'
[patent_app_type] => utility
[patent_app_number] => 13/882197
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 43262
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882197
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882197 | Use of Hepcidin Binding Nucleic Acids for Depletion of Hepcidin From the Body | Oct 30, 2011 | Abandoned |
Array
(
[id] => 8172203
[patent_doc_number] => 20120107825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR ASSESSING PATIENTS WITH REPRODUCTIVE FAILURE USING IMMUNE CELL-DERIVED MICRORNA'
[patent_app_type] => utility
[patent_app_number] => 13/284739
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21598
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107825.pdf
[firstpage_image] =>[orig_patent_app_number] => 13284739
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284739 | METHODS AND COMPOSITIONS FOR ASSESSING PATIENTS WITH REPRODUCTIVE FAILURE USING IMMUNE CELL-DERIVED MICRORNA | Oct 27, 2011 | Abandoned |
Array
(
[id] => 9042458
[patent_doc_number] => 20130245096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA'
[patent_app_type] => utility
[patent_app_number] => 13/881350
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 30269
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881350
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881350 | COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA | Oct 26, 2011 | Abandoned |
Array
(
[id] => 9095006
[patent_doc_number] => 20130274317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'DERIVATIVES OF SMALL INTERFERING RNAS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/883081
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7906
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883081
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883081 | DERIVATIVES OF SMALL INTERFERING RNAS AND USE THEREOF | Oct 25, 2011 | Abandoned |